{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2019:TNXKBJ67IP4HVOHMROO75XJ2NC","short_pith_number":"pith:TNXKBJ67","schema_version":"1.0","canonical_sha256":"9b6ea0a7df43f87ab8ec8b9dfedd3a68bf0ada908ac1f21a0db953eeb7a35484","source":{"kind":"arxiv","id":"1905.00241","version":1},"attestation_state":"computed","paper":{"title":"Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Abdel G. Babiker, Andrew Copas, A. Sarah Walker, Ian R. White, Mahesh K.B. Parmar, Matteo Quartagno, Rebecca M. Turner","submitted_at":"2019-05-01T10:00:14Z","abstract_excerpt":"Background. Non-inferiority (NI) trials are increasingly used to evaluate new treatments expected to have secondary advantages over standard of care, but similar efficacy on the primary outcome. When designing a NI trial with a binary primary outcome, the choice of effect measure for the NI margin has an important effect on sample size calculations; furthermore, if the control event risk observed is markedly different from that assumed, the trial can quickly lose power or the results become difficult to interpret. Methods. We propose a new way of designing NI trials to overcome the issues rais"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"1905.00241","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2019-05-01T10:00:14Z","cross_cats_sorted":[],"title_canon_sha256":"502e68be2f73e92c4814f692270a2bb7b4627efcb1f0c93b747158835af0fbe5","abstract_canon_sha256":"8d98e50eddaac0d963042c084041982715856465f76a7d391e33fa665a4c3cb7"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-17T23:47:13.370199Z","signature_b64":"PM04uJcqwu60nPlfkNMnV4KkPb0kyP9iyHNzWZj22k35Upu8IB9JpiNUNHVnD+DRsOsAgDxXKi2k1dH5R9W6CA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"9b6ea0a7df43f87ab8ec8b9dfedd3a68bf0ada908ac1f21a0db953eeb7a35484","last_reissued_at":"2026-05-17T23:47:13.369769Z","signature_status":"signed_v1","first_computed_at":"2026-05-17T23:47:13.369769Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Abdel G. Babiker, Andrew Copas, A. Sarah Walker, Ian R. White, Mahesh K.B. Parmar, Matteo Quartagno, Rebecca M. Turner","submitted_at":"2019-05-01T10:00:14Z","abstract_excerpt":"Background. Non-inferiority (NI) trials are increasingly used to evaluate new treatments expected to have secondary advantages over standard of care, but similar efficacy on the primary outcome. When designing a NI trial with a binary primary outcome, the choice of effect measure for the NI margin has an important effect on sample size calculations; furthermore, if the control event risk observed is markedly different from that assumed, the trial can quickly lose power or the results become difficult to interpret. Methods. We propose a new way of designing NI trials to overcome the issues rais"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1905.00241","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"1905.00241","created_at":"2026-05-17T23:47:13.369840+00:00"},{"alias_kind":"arxiv_version","alias_value":"1905.00241v1","created_at":"2026-05-17T23:47:13.369840+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1905.00241","created_at":"2026-05-17T23:47:13.369840+00:00"},{"alias_kind":"pith_short_12","alias_value":"TNXKBJ67IP4H","created_at":"2026-05-18T12:33:30.264802+00:00"},{"alias_kind":"pith_short_16","alias_value":"TNXKBJ67IP4HVOHM","created_at":"2026-05-18T12:33:30.264802+00:00"},{"alias_kind":"pith_short_8","alias_value":"TNXKBJ67","created_at":"2026-05-18T12:33:30.264802+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/TNXKBJ67IP4HVOHMROO75XJ2NC","json":"https://pith.science/pith/TNXKBJ67IP4HVOHMROO75XJ2NC.json","graph_json":"https://pith.science/api/pith-number/TNXKBJ67IP4HVOHMROO75XJ2NC/graph.json","events_json":"https://pith.science/api/pith-number/TNXKBJ67IP4HVOHMROO75XJ2NC/events.json","paper":"https://pith.science/paper/TNXKBJ67"},"agent_actions":{"view_html":"https://pith.science/pith/TNXKBJ67IP4HVOHMROO75XJ2NC","download_json":"https://pith.science/pith/TNXKBJ67IP4HVOHMROO75XJ2NC.json","view_paper":"https://pith.science/paper/TNXKBJ67","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=1905.00241&json=true","fetch_graph":"https://pith.science/api/pith-number/TNXKBJ67IP4HVOHMROO75XJ2NC/graph.json","fetch_events":"https://pith.science/api/pith-number/TNXKBJ67IP4HVOHMROO75XJ2NC/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/TNXKBJ67IP4HVOHMROO75XJ2NC/action/timestamp_anchor","attest_storage":"https://pith.science/pith/TNXKBJ67IP4HVOHMROO75XJ2NC/action/storage_attestation","attest_author":"https://pith.science/pith/TNXKBJ67IP4HVOHMROO75XJ2NC/action/author_attestation","sign_citation":"https://pith.science/pith/TNXKBJ67IP4HVOHMROO75XJ2NC/action/citation_signature","submit_replication":"https://pith.science/pith/TNXKBJ67IP4HVOHMROO75XJ2NC/action/replication_record"}},"created_at":"2026-05-17T23:47:13.369840+00:00","updated_at":"2026-05-17T23:47:13.369840+00:00"}